共 271 条
[1]
Majhail NS(2015)Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation Biol Blood Marrow Transplant 21 1863-1869
[2]
Farnia SH(2015)Indications for allo- and auto-SCT for haematological diseases , solid tumours and immune disorders: current practice in Europe Bone Marrow Transplant 50 1037-1056
[3]
Carpenter PA(2014)Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation Hematol Oncol 32 31-39
[4]
Champlin RE(2015)Mucositis: pathobiology and management Curr Opin Oncol 27 159-164
[5]
Crawford S(2013)Emerging evidence on the pathobiology of mucositis Support Care Cancer 21 2075-2083
[6]
Marks DI(2015)The impact of low-level laser therapy on Oral Mucositis and quality of life in patients undergoing hematopoietic stem cell transplantation using the oral health impact profile and the functional assessment of cancer therapy-bone marrow transplantation questionnaires Photomed Laser Surg 33 357-363
[7]
Omel JL(2011)Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT — results of a multicentre study Bone Marrow Transplant 46 727-732
[8]
Orchard PJ(2004)Predictors of Oral Mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia J Clin Oncol 22 1268-1275
[9]
Palmer J(2013)Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT Bone Marrow Transplant 48 1460-1464
[10]
Saber W(2016)Simultaneous quantification of the 8 human herpesviruses in allogeneic hematopoietic stem cell transplantation Transplantation 100 1363-1370